全文获取类型
收费全文 | 1315篇 |
免费 | 81篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 72篇 |
妇产科学 | 10篇 |
基础医学 | 145篇 |
口腔科学 | 38篇 |
临床医学 | 166篇 |
内科学 | 324篇 |
皮肤病学 | 20篇 |
神经病学 | 97篇 |
特种医学 | 196篇 |
外科学 | 109篇 |
综合类 | 49篇 |
预防医学 | 67篇 |
眼科学 | 13篇 |
药学 | 21篇 |
肿瘤学 | 52篇 |
出版年
2022年 | 8篇 |
2020年 | 10篇 |
2018年 | 14篇 |
2017年 | 12篇 |
2016年 | 9篇 |
2015年 | 18篇 |
2014年 | 16篇 |
2013年 | 34篇 |
2012年 | 36篇 |
2011年 | 41篇 |
2010年 | 40篇 |
2009年 | 36篇 |
2008年 | 46篇 |
2007年 | 63篇 |
2006年 | 65篇 |
2005年 | 41篇 |
2004年 | 50篇 |
2003年 | 32篇 |
2002年 | 33篇 |
2001年 | 36篇 |
2000年 | 34篇 |
1999年 | 33篇 |
1998年 | 36篇 |
1997年 | 34篇 |
1996年 | 50篇 |
1995年 | 26篇 |
1994年 | 20篇 |
1993年 | 27篇 |
1992年 | 31篇 |
1991年 | 29篇 |
1990年 | 38篇 |
1989年 | 26篇 |
1988年 | 51篇 |
1987年 | 30篇 |
1986年 | 33篇 |
1985年 | 25篇 |
1984年 | 20篇 |
1983年 | 26篇 |
1982年 | 11篇 |
1981年 | 19篇 |
1980年 | 9篇 |
1979年 | 11篇 |
1978年 | 11篇 |
1977年 | 18篇 |
1976年 | 11篇 |
1975年 | 11篇 |
1974年 | 16篇 |
1973年 | 11篇 |
1972年 | 7篇 |
1971年 | 12篇 |
排序方式: 共有1408条查询结果,搜索用时 0 毫秒
41.
Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression 总被引:18,自引:26,他引:18
Sullivan KM; Shulman HM; Storb R; Weiden PL; Witherspoon RP; McDonald GB; Schubert MM; Atkinson K; Thomas ED 《Blood》1981,57(2):267-276
Fifty-two of 175 (30%) survivors of allogeneic marrow transplantation developed chronic graft-versus-hose diseases (GVHD). Five with limited chronic GVHD had an indolent clinical course with involvement of only the skin and liver. Forty-seven with extensive chronic GVHD had an unfavorable multiorgan disorder that resembled several autoimmune diseases. Thirteen patients with extensive disease (group I) were not treated and only 2 survive with Karnofsky scores >- 70%. Mortality resulted from infections and morbidity from sica syndrome, pulmonary and hepatic insufficiency, scleroderma-like skin disease, and contractures. Another 13 (group II) received a median of 8 mo prednisone and/or a brief course of antithymocyte globulin, and 3 survive without disability. The other 21 (group III) were treated with a combination of prednisone (1.0 mg/kg/q.o.d.) and either cyclophosphamide, procarbazine, or azathioprine (all 1.5 mg/kg/day) for a median of 13 mo. Combination therapy was well tolerated with only modest myelotoxicity. Fifteen in group III had a good and 4 a fair response to treatment while 2 with no response died. Azathioprine and prednisone was the most effective regimen. All therapy has been discontinued in 12 group III patients: GVHD returned in 5 (including 2 who died in spite of retreatment) while 7 remain free of GVHD for a median of 11 (range 6-30) mo observation. Only I group III survivor is disabled and 16 of the original 21 are alive 2-4 yr after transplant with Karnofsky scores of 70%-100%. Thus, combination immmunosuppression appears to favorably affect and, in some cases, premanently arrest the adverse natural course of extensive chronic GVHD. 相似文献
42.
Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients 总被引:4,自引:3,他引:4
Storb R; Doney KC; Thomas ED; Appelbaum F; Buckner CD; Clift RA; Deeg HJ; Goodell BW; Hackman R; Hansen JA; Sanders J; Sullivan K; Weiden PL; Witherspoon RP 《Blood》1982,59(2):236-246
Sixty-five multiply transfused patients with severe aplastic anemia were given cyclophosphamide followed by grafts anemia were given cyclophosphamide followed by grafts from HLA-identical siblings. The effect of the administration of viable donor buffy coat cells following the marrow inoculum was evaluated with regard to graft rejection and survival. Results in 43 patients so treated are presented along with those in 22 concurrent patients given marrow alone. Most patients given buffy coat had positive in vitro tests of sensitization indicating a high risk for graft rejection, while all but one of the patients given marrow alone had negative tests. Thirty of the 43 (70%) patients given marrow and buffy coat are alive between 10 and 61 mo (median 36) after grafting; 4 died after graft rejection and 6 with acute or chronic graft-versus-host disease (GVHD). Eleven of the 22 (50%) patients given marrow alone are alive between 29 and 65 mo (median 52); 7 died after graft rejection and 3 with GVHD. The addition of buffy coat cell infusions to the marrow inoculum reduced the risk of rejection and increased survival in the currently reported transfused patients when compared to patients grafted before 1976. However, there was an increased risk of chronic GVHD. Recipients of marrow from female donors survived slightly better (73%) than recipients of male marrow (58%). 相似文献
43.
44.
α-葡萄糖苷酶抑制剂治疗2型糖尿病的系统评价 总被引:4,自引:0,他引:4
目的评价α-葡萄糖苷酶抑制剂治疗2型糖尿病患者的效果。方法检索Cochrane图书馆、MEDLINE、EMBASE、CurrentContents、LILACS在研试验数据库,主题为α-葡萄糖苷酶抑制剂的综述的参考文献,并联系纳入试验的专家与实施者。最近检索日期为2003年月12月(CurrentContents)和2003年4月(其他数据库)。纳入α-葡萄糖苷酶抑制剂单一疗法与其它干预比较,治疗2型糖尿病疗程至少12周的随机对照试验,并且试验至少包括以下结局之一:病死率、患病率、生活质量、血糖控制、血脂、胰岛素水平、体重、不良事件。两名评价者独立阅读所有摘要,评价质量并提取数据,分歧通过协商解决或由第三位评价者裁决。由一位统计学家在对提取数据输入数据库时进行检查。我们尽量联系所有作者以核实数据。结果共纳入41个试验、8130例受试者,其中30个针对阿卡波糖,7个针对米格列醇,1个针对优格列波糖,还有3个为不同α-葡萄糖苷酶抑制剂间的比较。绝大多数研究疗程为24周,仅有2个研究超过1年。与安慰剂相比,阿卡波糖血糖控制效果更好:糖化血红蛋白–0.8%[95%CI(–0.9,–0.7)],空腹血糖–1.1mmol/L[95%CI(–1.4,–0.9)],负荷血糖–2.3mmol/L[95%CI(–2.7,–1.9)],阿卡波糖对糖化血红蛋白的作用呈非剂量依赖。我们发现其可降低负荷胰岛素,但对血脂和体重未见临床相关的作用。不良反应主要来自胃肠道且与剂量相关。相对于磺脲,阿卡波糖将空腹和负荷胰岛素水平分别降低至–24.8pmol/L[95%CI(–43.3,–6.3)]和–133.2pmol/L[95%CI(–184.5,–81.8)],但阿卡波糖引起的不良反应更多。结论关于α-葡萄糖苷酶抑制剂是否影响2型糖尿病患者的病死率和患病率仍不清楚。相反,其对血糖控制或胰岛素水平作用明显,对血脂和体重的作用差异无统计学意义。α-葡萄糖苷酶抑制剂更长疗程的效果仍不确定。阿卡波糖剂量超过50mg(TID)时不能进一步影响糖化血红蛋白水平,不良反应反而更多,与磺脲相比,α-葡萄糖苷酶抑制剂降低了空腹和负荷胰岛素水平,但在血糖控制和不良反应方面存在不利影响。 相似文献
45.
46.
René Friedland 《Optimal control applications & methods.》2010,31(6):567-580
In the so‐called sole‐owner‐case of a renewable resource harvesting, it is known that the optimal policy includes a period with no harvesting, if the population is insufficiently small. Therefore, the fishermen have no income in this phase. To avoid this problem, the optimal control problem was enhanced in two different ways. First, the capital accumulation rate was bounded from below what generated a global mixed constraint. Second, lower bounds for the capital stock at a finite number of time points were introduced, which at first led to one and afterwards several isolated inequality constraints. For the resulting constrained optimal control problems, the necessary conditions were derived and an iterative algorithm was implemented to calculate the solutions in several numerical examples. Copyright © 2010 John Wiley & Sons, Ltd. 相似文献
47.
Graham Cooke Sally Hargreaves Jana Natkunarajah Gurjinder Sandhu Devesh Dhasmana Joseph Eliahoo Alison Holmes Jon S Friedland 《BMC health services research》2007,7(1):113
Background
The UK has witnessed a considerable increase in immigration in the past decade. Migrant may face barriers to accessing appropriate health care on arrival and the current focus on screening certain migrants for tuberculosis on arrival is considered inadequate. We assessed the implications for an inner-City London Infectious Diseases Department in a high migrant area. 相似文献48.
49.
50.
A Adachi G J Kleiner G H Bezahler W M Greston G H Friedland 《The Journal of reproductive medicine》1985,30(2):145-148
Abdominal wall actinomycosis without pelvic organ involvement in users of intrauterine contraceptive devices (IUDs) has not been reported on previously. We encountered one such patient, whose uterine cervix was colonized superficially with Actinomyces. We suggest that systemic actinomycosis be included in the differential diagnosis of pain in IUD users when Actinomyces is found on Papanicolaou smears or in endocervical curettings. Such patients should be treated with appropriate antibiotic therapy, especially prior to any surgical intervention. 相似文献